Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| Sculpting nuclear envelope identity from the endoplasmic reticulum during the cell cycle. | Nucleus | 2024 | 38238284 | PubTator, text mining | PubMed |
| Triptolide promotes nerve repair after cerebral ischemia reperfusion injury by regulating the NogoA/NgR/ROCK pathway. | Folia Neuropathol | 2024 | 38174687 | PubTator, text mining | PubMed |
| Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: an integrative study of single-nucleus transcriptomes and genetic association. | Alzheimers Res Ther | 2024 | 38167548 | PubTator, text mining | PubMed |
| AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies. | BioDrugs | 2024 | 37878215 | PubTator, text mining | PubMed |
| Regenerative medicine strategies for chronic complete spinal cord injury. | Neural Regen Res | 2024 | 37843217 | PubTator, text mining | PubMed |
| mHapBrowser: a comprehensive database for visualization and analysis of DNA methylation haplotypes. | Nucleic Acids Res | 2024 | 37831137 | PubTator, text mining | PubMed |
| Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice. | bioRxiv | 2024 | 37693381 | PubTator, text mining | PubMed |
| Lin28 as a therapeutic target for central nervous system regeneration and repair. | Neural Regen Res | 2024 | 37488899 | PubTator, text mining | PubMed |
| Pulmonary hypertension and insulin resistance: a mechanistic overview. | Front Endocrinol (Lausanne) | 2023 | 38239990 | PubTator, text mining | PubMed |
| Neuromodulation to guide circuit reorganization with regenerative therapies in upper extremity rehabilitation following cervical spinal cord injury. | Front Rehabil Sci | 2023 | 38234989 | PubTator, text mining | PubMed |
| Proteome-Wide Fragment-Based Ligand and Target Discovery. | Isr J Chem | 2023 | 38213795 | PubTator, text mining | PubMed |
| AAV for Gene Therapy in Ocular Diseases: Progress and Prospects. | Research (Wash D C) | 2023 | 38188726 | PubTator, text mining | PubMed |
| Editorial: Otitis media susceptibility due to genetic variants. | Front Genet | 2023 | 38152651 | PubTator, text mining | PubMed |
| Inhibition of the Nogo-pathway in experimental spinal cord injury: a meta-analysis of 76 experimental treatments. | Sci Rep | 2023 | 38129508 | PubTator, text mining | PubMed |
| Mapping the protein-protein interactome in the tumor immune microenvironment. | Antib Ther | 2023 | 38098892 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review. | Cancer Med | 2023 | 38098217 | PubTator, text mining | PubMed |
| Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice. | Cell Death Discov | 2023 | 38097540 | PubTator, text mining | PubMed |
| Regulatory mechanism of macrophage polarization based on Hippo pathway. | Front Immunol | 2023 | 38090595 | PubTator, text mining | PubMed |
| Genetic Studies of Actinic Keratosis Development: Where Are We Now? | Ann Dermatol | 2023 | 38086352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=7